Artiva Biotherapeutics (ARTV) EBITDA (2023 - 2024)
Historic EBITDA for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q4 2024 value amounting to -$16.6 million.
- Artiva Biotherapeutics' EBITDA fell 3846.67% to -$16.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$65.8 million, marking a year-over-year change of. This contributed to the annual value of -$65.8 million for FY2024, which is 13162.75% down from last year.
- As of Q4 2024, Artiva Biotherapeutics' EBITDA stood at -$16.6 million, which was down 3846.67% from -$17.3 million recorded in Q3 2024.
- In the past 5 years, Artiva Biotherapeutics' EBITDA ranged from a high of $11.4 million in Q3 2023 and a low of -$17.9 million during Q2 2024